ArticleScientific reports2026
Quality, chemical composition, and antimicrobial potential of Citrus peel essential oils against urinary tract infection pathogens.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urinary tract infection (UTI) is one of the most common microbial infections worldwide, and the growing resistance to conventional antibiotics highlights the need for alternative therapies. This study evaluated the quality, chemical composition, and antimicrobial activity of Citrus peel essential oils (CPEOs) against six UTI-causing pathogens: Pseudomonas aeruginosa ATCC 27853, Klebsiella pneumoniae ATCC 2537, Enterococcus faecalis ATCC 29212, Staphylococcus aureus ATCC 6538, Candida albicans ATCC 10231, and Aspergillus niger ATCC 6275. Essential oils were extracted from the peels of C. aurantiifolia, C. limon, C. nobilis, C. amblycarpa, and C. sinensis, and their quality parameters were assessed in comparison with ISO standards. The chemical composition determined using gas chromatography-mass spectrometry (GC-MS), revealed limonene, β-pinene, γ-terpinene, and linalool as the predominant constituents, which were further validated by Fourier-transform infrared spectroscopy (FTIR) analysis. Antimicrobial activity was examined using inhibition zone and minimum inhibitory concentration (MIC) assays. The results showed that C. limon essential oil (CLEO) exhibited the strongest antimicrobial activity, with inhibition zones reaching up to 81.17 ± 0.827 mm against K. pneumoniae and MIC values as low as 2 µg/mL against C. albicans. In contrast, C. sinensis and C. nobilis essential oils displayed weaker activity, and no significant inhibition was observed against P. aeruginosa. The strong antimicrobial activity of CLEO is likely associated with its higher γ-terpinene content, which is known to disrupt microbial membranes and induce cell death. Overall, these findings highlight CPEOs, particularly CLEO, as promising natural antimicrobial agents for the prevention and management of UTI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.